Permitting patients to pay for participation in clinical trials: the advent of the P4 trialReport as inadecuate




Permitting patients to pay for participation in clinical trials: the advent of the P4 trial - Download this document for free, or read online. Document in PDF available to download.

Medicine, Health Care and Philosophy

, Volume 20, Issue 2, pp 219–227

First Online: 18 October 2016DOI: 10.1007-s11019-016-9741-2

Cite this article as: Shaw, D., de Wert, G., Dondorp, W. et al. Med Health Care and Philos 2017 20: 219. doi:10.1007-s11019-016-9741-2

Abstract

In this article we explore the ethical issues raised by permitting patients to pay for participation P4 in clinical trials, and discuss whether there are any categorical objections to this practice. We address key considerations concerning payment for participation in trials, including patient autonomy, risk-benefit and justice, taking account of two previous critiques of the ethics of P4. We conclude that such trials could be ethical under certain strict conditions, but only if other potential sources of funding have first been explored or are unavailable.

KeywordsClinical trials Research ethics Participatory research Exploitation Patient participation Crowdfunding 



Author: David Shaw - Guido de Wert - Wybo Dondorp - David Townend - Gerard Bos - Michel van Gelder

Source: https://link.springer.com/



DOWNLOAD PDF




Related documents